Meru Health Program Versus Waitlist Control for Adults With Depression
Randomized Controlled Trial of the Meru Health Program Versus Waitlist Control for Adults With Depression
1 other identifier
interventional
100
1 country
1
Brief Summary
This is a randomized controlled trial (RCT) of the Meru Health Program (MHP) versus a waitlist (WL) control group, which will be offered access to the MHP after the waitlist period (12 weeks) is over, for adults with depression. The Meru Health Program (MHP) is a 12-week mobile mental health intervention delivered via Smartphone app that includes components of several evidence-based treatments (Cognitive Behavioral Therapy, Behavioral Activation Therapy, Mindfulness Meditation) and also several promising therapies (heart rate variability-biofeedback \[HRVB\], nutritional psychiatry, sleep training) that is overseen by a licensed clinical therapist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 21, 2020
CompletedFirst Submitted
Initial submission to the registry
January 24, 2021
CompletedFirst Posted
Study publicly available on registry
February 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedJuly 13, 2023
July 1, 2023
8 months
January 24, 2021
July 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depression
Mean change in Patient Health Questionnaire-9 item depression scale during the program. Scores range from 0 to 27, with higher scores indicative of more depression.
12 weeks
Secondary Outcomes (7)
Anxiety
12 weeks
Burnout
12 weeks
Worker Productivity and Activity Impairment
12 weeks
Resilience
12 weeks
Insomnia
12 weeks
- +2 more secondary outcomes
Other Outcomes (3)
Patient-reported program satisfaction
12 weeks
Therapist rating
12 weeks
System usability
12 weeks
Study Arms (2)
Meru Health Program
EXPERIMENTALThe Meru Health Program (MHP) is a 12-week online mobile digital mental health clinic delivered via Smartphone app that includes components of several evidence-based treatments (Cognitive Behavioral Therapy, Behavioral Activation Therapy, Mindfulness Meditation) and also several promising therapies (heart rate variability-biofeedback \[HRVB\], nutritional psychiatry, sleep training) and a group support component that is overseen by a licensed clinical therapist.
Waitlist
NO INTERVENTION12 week waitlist
Interventions
Each week of the 12 week program follows a different theme. Patients and therapists interact asynchronously after their initial Zoom-based intake call. Psychiatrists and medical doctors are available for consults if needed.
Eligibility Criteria
You may qualify if:
- years or older
- Own a Smartphone
- PHQ-9\>9
- Lives in Colorado
You may not qualify if:
- Screen positive for a psychotic disorder, bipolar disorder, alcohol or drug use disorder, or suicidal plans
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Online
Denver, Colorado, 80014, United States
Related Publications (1)
Forman-Hoffman VL, Sihvonen S, Wielgosz J, Kuhn E, Nelson BW, Peiper NC, Gould CE. Therapist-supported digital mental health intervention for depressive symptoms: A randomized clinical trial. J Affect Disord. 2024 Mar 15;349:494-501. doi: 10.1016/j.jad.2024.01.057. Epub 2024 Jan 9.
PMID: 38211747DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valerie F Hoffman, PhD, MPH
Meru Health, Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Data analyst will be blind to study group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2021
First Posted
February 4, 2021
Study Start
August 21, 2020
Primary Completion
April 15, 2021
Study Completion
December 30, 2021
Last Updated
July 13, 2023
Record last verified: 2023-07